OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation
Kenneth Blum, Mark S. Brodie, Subhash C. Pandey, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 1009-1009
Open Access | Times Cited: 12
Kenneth Blum, Mark S. Brodie, Subhash C. Pandey, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 1009-1009
Open Access | Times Cited: 12
Showing 12 citing articles:
Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography
Kenneth Blum, David Baron, Thomas McLaughlin, et al.
(2024) Vol. 8, Iss. 1
Closed Access | Times Cited: 5
Kenneth Blum, David Baron, Thomas McLaughlin, et al.
(2024) Vol. 8, Iss. 1
Closed Access | Times Cited: 5
Criterion validity of the genetic addiction risk severity (GARS) as a marker of reward deficiency in polydrug addiction: a multi-center study
Kenneth Blum, Brett C. Haberstick, Andrew Smolen, et al.
Journal of Translational Genetics and Genomics (2025) Vol. 9, Iss. 2, pp. 76-100
Open Access
Kenneth Blum, Brett C. Haberstick, Andrew Smolen, et al.
Journal of Translational Genetics and Genomics (2025) Vol. 9, Iss. 2, pp. 76-100
Open Access
Hypothesizing glucagon-like peptide 1 (GLP-1), agonists promote hypodopaminergia, resulting in heightened addictive reward-seeking and altered mood: Breaking the bubble and adding salt to a wound
Kenneth Blum, Catherine A. Dennen, Kai-Uwe Lewandrowski, et al.
Medical Hypotheses (2025), pp. 111612-111612
Closed Access
Kenneth Blum, Catherine A. Dennen, Kai-Uwe Lewandrowski, et al.
Medical Hypotheses (2025), pp. 111612-111612
Closed Access
Neurogenetics and Epigenetics of Loneliness
Abdalla Bowirrat, Igor Elman, Catherine A. Dennen, et al.
Psychology Research and Behavior Management (2023) Vol. Volume 16, pp. 4839-4857
Open Access | Times Cited: 10
Abdalla Bowirrat, Igor Elman, Catherine A. Dennen, et al.
Psychology Research and Behavior Management (2023) Vol. Volume 16, pp. 4839-4857
Open Access | Times Cited: 10
A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy
Kai‐Uwe Lewandrowski, Alireza Sharafshah, John C. Elfar, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3
Kai‐Uwe Lewandrowski, Alireza Sharafshah, John C. Elfar, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3
How to Combat the Global Opioid Crisis.
Catherine Dennen A, Kenneth Blum, Eric Braverman R, et al.
PubMed (2023) Vol. 5, Iss. 4
Closed Access | Times Cited: 8
Catherine Dennen A, Kenneth Blum, Eric Braverman R, et al.
PubMed (2023) Vol. 5, Iss. 4
Closed Access | Times Cited: 8
The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical Research
Panayotis K. Thanos, Colin Hanna, Abrianna Mihalkovic, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1164-1164
Open Access | Times Cited: 7
Panayotis K. Thanos, Colin Hanna, Abrianna Mihalkovic, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1164-1164
Open Access | Times Cited: 7
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences
Kenneth Blum, Abdalla Bowirrat, David Baron, et al.
Gene & Protein in Disease (2024) Vol. 3, Iss. 1, pp. 1966-1966
Open Access | Times Cited: 2
Kenneth Blum, Abdalla Bowirrat, David Baron, et al.
Gene & Protein in Disease (2024) Vol. 3, Iss. 1, pp. 1966-1966
Open Access | Times Cited: 2
Epigenetic Effects of Psychoactive Drugs
Rania Ahmed, Kenneth Blum, Panayotis K. Thanos
Current Pharmaceutical Design (2023) Vol. 29, Iss. 27, pp. 2124-2139
Closed Access | Times Cited: 4
Rania Ahmed, Kenneth Blum, Panayotis K. Thanos
Current Pharmaceutical Design (2023) Vol. 29, Iss. 27, pp. 2124-2139
Closed Access | Times Cited: 4
“Preaddiction” construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation
Kenneth Blum, Igor Elman, Catherine A. Dennen, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 21, pp. 1181-1181
Open Access | Times Cited: 7
Kenneth Blum, Igor Elman, Catherine A. Dennen, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 21, pp. 1181-1181
Open Access | Times Cited: 7
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family
Catherine A. Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1864-1864
Open Access | Times Cited: 6
Catherine A. Dennen, Kenneth Blum, Abdalla Bowirrat, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1864-1864
Open Access | Times Cited: 6
Reward Deficiency Syndrome Solution System (RDSSS) A Genetically Driven Putative Inducer of “Dopamine Homeostasis” as a Futuristic Alternative to Enhance Rehabilitation Instead of Incarceration
Kenneth Blum, Richard Green, Paul Mullen, et al.
Asian Journal of Complementary and Alternative Medicine (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Kenneth Blum, Richard Green, Paul Mullen, et al.
Asian Journal of Complementary and Alternative Medicine (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 2
